Quick Answer
Turn Therapeutics Inc. reported Operating Income Loss of -$5.86 million for the year ending 2025.
- Turn Therapeutics Inc. showed a decrease of -226.0% in Operating Income Loss from 2024 to 2025.
- This data is from Turn Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: -$5.86 million | Fiscal year 2024: -$1.80 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: